Vir Biotechnology, Inc.
VIR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $170 | $211 | $274 | $223 |
| Short-Term Investments | $336 | $395 | $528 | $682 |
| Receivables | $0 | $0 | $0 | $5 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $39 | $130 | $131 | $132 |
| Total Curr. Assets | $546 | $736 | $932 | $1,042 |
| Property Plant & Equip (Net) | $122 | $126 | $120 | $123 |
| Goodwill | $17 | $17 | $17 | $17 |
| Intangibles | $8 | $8 | $8 | $8 |
| Long-Term Investments | $304 | $286 | $218 | $190 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $23 | $20 | $12 | $18 |
| Total NC Assets | $474 | $457 | $376 | $356 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,019 | $1,193 | $1,308 | $1,399 |
| Liabilities | – | – | – | – |
| Payables | $7 | $12 | $4 | $5 |
| Short-Term Debt | $9 | $9 | $8 | $8 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $10 | $12 | $13 |
| Other Curr. Liab. | $59 | $74 | $114 | $94 |
| Total Curr. Liab. | $75 | $105 | $137 | $120 |
| LT Debt | $91 | $93 | $88 | $90 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $57 | $47 | $38 | $39 |
| Total NC Liab. | $148 | $140 | $127 | $129 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $100 | $102 | $96 | $98 |
| Total Liabilities | $223 | $245 | $264 | $248 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,155 | -$992 | -$881 | -$760 |
| AOCI | -$2 | -$2 | -$2 | -$2 |
| Other Equity | $1,953 | $1,941 | $1,927 | $1,912 |
| Total Equity | $796 | $947 | $1,044 | $1,150 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,019 | $1,193 | $1,308 | $1,399 |
| Net Debt | -$70 | -$109 | -$177 | -$125 |